Diagnosis of aminoacidopathies constitutes a challenge in a developing country with high positive consanguinity rate and no newborn screening programs. The number of diagnosed inborn errors of amino acid metabolism is growing constantly due to the availability of recent analytical technique as tandem mass spectrometry (LC/MS/MS). This study highlights the importance of clinical awareness among physicians in patients presenting with unexplained neurological signs and alarming features that are commonly associated with metabolic diseases.
INTRODUCTION

Inborn errors of metabolism (IEM) cause hereditary metabolic diseases
(HMD) and they result from the lack of activity of one or more specific enzymes or defects in the transportation of proteins. The consequences can usually be the accumulation of substances present in small amounts, the deficiency of critical intermediary products, the deficiency of specific final products or furthermore the noxious excess of products of alternative metabolic pathways (Waber, 1990) . It seems to be common in the Middle East and North Africa, where high consanguinity rates still prevail due to frequents marriages between close relatives (Teebi, 2006) . They present clinically in a variety of ways, involving virtually any organ or tissue of the body, and accurate diagnosis is important both for treatment and prevention of disease in other family members (Clarke, 2006) . There are a few Arab countries in the Middle East and North Africa region that have started a new born screening program (NBS), while others have either a limited hospital-based selective NBS or have just completed pilot studies (AlGazali ; .
Twenty amino acids are involved in metabolism. Each amino acid is further broken down into ammonia, carbon dioxide, and water. Disorders that affect the metabolism of amino acids include phenylketonuria, tyrosinemia, homocystinuria, non ketotic hyperglycinemia and maple syrup urine disease.
These disorders are autosomal recessive, and all may be diagnosed by analyzing amino acid concentrations in the body fluids (Hoffmann; .
Tandem mass spectrometry (MS/MS) is an advanced technology that has the ability to identify more than 30 diseases by testing compounds from a single dried blood sample collected from infants during their second to third Abd El-Khalek, et al Vol. 37, No.3, March 2017 49 day of life (Mcdonald; . Analysis for identifying each condition is simultaneous and rapid with high specific sensitivity (100%) and specificity (100%). With this technology, many high income countries, such as Italy, Denmark, Canada, Australia, Qatar, and Taiwan have expanded their neonatal screening programme in order to cover more IEM, which in the past consisted only of phenylketonuria (PKU) (Mcdonald ; . IEM are not rare diseases when we observe their cumulative incidence which is about one in every 5000 live births. Nevertheless, the prevalence of each disease has many variables, especially relating to race. For specific diseases include: 1 in 500 for familial hypercholesterolemia 1 in 12,000 for phenylketonuria (Martins; et al., 1995) ; 1 in 15,000 for organic acidurias (Seymour et al., 1997) ; 1 in 60,000 for glycogen storage disease (Martins; et al., 1995) ; 1 in 45,000 for galactosemia (Seymour et al., 1997) 1 in 100,000
for homocystinuria and 1 in 290,000 for maple syrup urine disease (Seymour; et al., 1997) .
In countries where consanguinity rates are high, offspring can inherit the disease from a common ancestor, leading to an increased incidence of inherited disorders. The inbreeding coefficient factor ranges from 0.00004 to 0.0008 .In Canada and from 0.001 to 0.005 in the United States (Nussbum; . (Niu; . 
SUBJECTS AND METHODS
This
B) Data concerning MSUD: It is obvious that number of MSUD patients in
Upper Egypt represents 28.5% while it was again higher in Lower Egypt 71.5%. Representing consanguinity percentage, it is clear that high consanguinity rate was among MSUD families (1stcousin consanguinity) and the large number of cases was from Cairo. 
F) Data concerning homocystinuria.:
It is obvious that number of homocystinuria patients was 4 patients. Representing consanguinity percentage, it is clear that high consanguinity rate among homocystinuria families and the large number of cases was also from Cairo (2 patients).
Figure (6): Distribution of patients with Homocystinuria in Governorates.
The large number of cases was from Cairo. Abd El-Khalek, et al Vol. 37, No.3, March 2017 57 consanguinity was found among MSUD families (89.9 %) and (62.2%)
showed first cousin consanguinity.
In our study, we had 15 patients with non-ketotic hyperglycinaemia NKH in 15 families. First cousin consanguinity was found in (53.33%). Sex distribution was 7 (46.66%) males and 8 (53.33%) females. As regard tyrosinemia type 1, we had 14 cases in 11 families. Consanguinity was (92.85%) and first cousin consanguinity was (50%). Moreover, we had three patients with arginimia in three families. First cousin consanguinity was found in (66.66). Sex distribution was 2 (66.66%) males and 2 (33.33%)
females. As regard homocystinuria, we had 4 cases in 4 families.
Consanguinity was (50%) and first cousin consanguinity was (25%). In this study, we had 4 patients with Citruillinimia in 4 families. High level of consanguinity was found among citruillinimia families (100%).
Consanguineous marriages are very common in Egypt (35.3%) (Shawky et al., 2011) which lead to increase the risk of metabolic disorders. In this study, consanguinity was high (72%) and 26.5 % of the families were found to have a positive family history of an IEM or of unexplained death among their families which with other studies done in Oman (Al Riyami et al., 2012) , Jordan (Al-Qaqa et al., 2012) and libya (Alobaidy, 2013) . These findings are consistent with the recessive autosomal inheritance of IEMs and reflect the significant contribution of consanguinity in Egypt in this particular health problem.
The high rates of IEM diseases can be attributed to several factors including high rate of traditional consanguineous marriages, which increases the frequency of autosomal recessive diseases; large family sizes, which may increase the number of affected children in families with autosomal recessive conditions; the shortage of genetic services and inadequate health care prior to and during pregnancy.
The only way for treatment of pku patients is decreasing its level with
Phenylalanine-free milk formula with a diet low in protein. Figure (8) illustrate the level of phenylalanine at onset (pretreated) and its level after treatment with previous formula for 3 months of following up in male and female patients. Abd El-Khalek, et al Vol. 37, No.3, March 2017 59 All patients are treated with BCAA-free milk formula and a diet that contains defined quantities of BCAAs and which is regularly controlled by measuring the levels of the BCAAs in plasma. Figure (9 ) illustrate the level of leucine/ile at onset (pretreated) and its level after treatment with BCAA free milk formula and a diet low in protein for 3 months following up in male and female MSUD patients. 2-The lack of newborn screening program and specialized healthcare centers in Egypt have contributed to the delay in diagnosis of numbers of patients.
3-Positive consanguinity which was high in our study (84.3%) has been recognized as the main social factor related to the high prevalence of IEM 
